KIFFIK BIOMEDICAL EUROPE LTD - NORTHAMPTON
Company Profile | Company Filings |
Overview
KIFFIK BIOMEDICAL EUROPE LTD is a Private Limited Company from NORTHAMPTON UNITED KINGDOM and has the status: Active.
KIFFIK BIOMEDICAL EUROPE LTD was incorporated 2 years ago on 18/11/2021 and has the registered number: 13751643. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
KIFFIK BIOMEDICAL EUROPE LTD was incorporated 2 years ago on 18/11/2021 and has the registered number: 13751643. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 30/09/2024.
KIFFIK BIOMEDICAL EUROPE LTD - NORTHAMPTON
This company is listed in the following categories:
26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
26600 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
PACIOLI HOUSE 9 BROOKFIELD
NORTHAMPTON
NN3 6WL
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
18/11/2023 | 02/12/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR HOWARD PETERSON | Feb 1963 | American | Director | 2021-11-18 | CURRENT |
MR NICHOLAS MARR | Feb 1976 | American | Director | 2021-11-18 | CURRENT |
MR LESLIE LINDSAY | Sep 1956 | British | Director | 2021-11-18 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Kiffik Biomedical Inc. | 2021-11-18 - 2021-11-18 | Northampton |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Kiffik Biomedical Europe Ltd - Accounts to registrar (filleted) - small 23.1.2 | 2023-07-08 | 31-12-2022 | £6,592 Cash £-16,605 equity |